IAVI Awarded $36 Million From BARDA for Bundibugyo Virus Vaccine Development
October 28, 2026
Initial award funds process development, manufacturing, and clinical evaluation of a single-dose vaccine candidate through strategic partnerships with Hilleman Laboratories, SK bioscience, and IDT Biologika NEW YORK, NY, SINGAPORE, SG